V021-2086 Screening compound: 1-({1-[(5-methyl-2-furyl)methyl]-4-[3-(trifluoromethyl)phenyl]tetrahydro-1H-pyrrol-3-yl}methyl)-4-phenylpiperazine

V021-2086 Screening compound: 1-({1-[(5-methyl-2-furyl)methyl]-4-[3-(trifluoromethyl)phenyl]tetrahydro-1H-pyrrol-3-yl}methyl)-4-phenylpiperazine
V021-2086 Screening compound: 1-({1-[(5-methyl-2-furyl)methyl]-4-[3-(trifluoromethyl)phenyl]tetrahydro-1H-pyrrol-3-yl}methyl)-4-phenylpiperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V021-2086
1-({1-[(5-methyl-2-furyl)methyl]-4-[3-(trifluoromethyl)phenyl]tetrahydro-1H-pyrrol-3-yl}methyl)-4-phenylpiperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V021-2086

Molecular Formula

C28H32F3N3O (C28 H32 F3 N3 O)

Compound Name

1-({1-[(5-methyl-2-furyl)methyl]-4-[3-(trifluoromethyl)phenyl]tetrahydro-1H-pyrrol-3-yl}methyl)-4-phenylpiperazine

IUPAC name

1-({1-[(5-methylfuran-2-yl)methyl]-4-[3-(trifluoromethyl)phenyl]pyrrolidin-3-yl}methyl)-4-phenylpiperazine

SMILES

Cc1ccc(CN(CC2CN(CC3)CCN3c3ccccc3)CC2c2cccc(C(F)(F)F)c2)o1

InChI

InChI=1S/C28H32F3N3O/c1-21-10-11-26(35-21)19-33-18-23(27(20-33)22-6-5-7-24(16-22)28(29,30)31)17-32-12-14-34(15-13-32)25-8-3-2-4-9-25/h2-11,16,23,27H,12-15,17-20H2,1H3

InChI Key

OQDYENVDNVDKFF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19928058

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

483.58

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.670

Distribution Coefficient, logD

2.873

Water Solubility, LogSw

-5.59

Polar Surface Area

18.188

Acid Dissociation Constant (pKa)

23.31

Base Dissociation Constant (pKb)

10.20

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

42.86

V021-2086 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Anti-HIV1 Library (19540 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
Agro:
  • Agro

References: we are preparing a list of scientific research reports with V021-2086 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V021-2086?
Check Price and Availability of V021-2086, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V021-2086 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V021-2086
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V021-2086
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V021-2086 available by request